The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

GL261 tumors were studied sooner after induction (17±0 vs 30±5 days post-injection, p=0.032), explaining the lower animal weights in this cohort (22.4±0.6 vs 25.7±0.9 g, p=0.017). DCE T1-weighted MRI ...

Botox can cause side effects that range from mild to serious. Examples include headache, injection site reactions, and urinary retention. If side effects from Botox become difficult to tolerate ...

Rotating can help reduce pain when ongoing injections are needed. It may also reduce the risk of tissue scarring. Subcutaneous injections are those delivered in the fatty tissue that lies between the ...

Side effects of biologic drugs may include: respiratory infections headaches flu-like symptoms swelling, itching, or a rash at the injection site urinary tract infection Two types of biologic ...

You may have already tried other treatments for your arthritis. These may have included over-the-counter pain medicines and corticosteroid injections. If you still have significant symptoms, ...

Instead, he listed them on iPads handed to patients after they arrived, and instructed his employees never to take pictures of him performing injections, prosecutors said. When clients complained ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, Wegovy, and Mounjaro. The research involved over two million patients and ...

That could soon change. Eisai, the company that makes Leqembi, said it asked the Food and Drug Administration (FDA) to approve a version of the drug that is given as a subcutaneous injection—a shot ...

The Dec. 27, 2024, Food and Drug Administration (FDA) approval of the subcutaneous injection formulation of Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) for patients with solid tumors opened up ...